Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives $2.13 Average PT from Analysts
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has earned an average recommendation of “Hold” from the nine analysts that are covering the stock, Marketbeat reports. Five analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year price objective among analysts […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has earned an average recommendation of “Hold” from the nine analysts that are covering the stock, Marketbeat reports. Five analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year price objective among analysts […]
